4//SEC Filing
Nosenzo John 4
Accession 0001578563-23-000026
CIK 0001665988other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:45 PM ET
Size
8.1 KB
Accession
0001578563-23-000026
Insider Transaction Report
Form 4
Nosenzo John
Chief Commercial Officer
Transactions
- Sale
Class A Common Stock
2022-04-01$14.07/sh−40$563→ 87,250 total - Sale
Class A Common Stock
2022-07-01$6.73/sh−95$639→ 87,155 total - Sale
Class A Common Stock
2022-10-03$7.00/sh−7$49→ 87,148 total
Footnotes (2)
- [F1]Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan.
- [F2]Includes an aggregate of 3,398 shares of Class A common stock purchased under the Company's 2021 Employee Stock Purchase Plan. This number has also been adjusted to account for a scrivener's error in a prior filing which attributed an acquisition of 40 shares under the Company's 2021 Employee Stock Purchase Plan.
Documents
Issuer
Bioventus Inc.
CIK 0001665988
Entity typeother
Related Parties
1- filerCIK 0001835973
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:45 PM ET
- Size
- 8.1 KB